Tesamorelin injection is a hormone similar to the one normally released from the hypothalamus gland in the brain. It is used to reduce excess fat (lipodystrophy) in the stomach area in patients with human immunodeficiency virus (HIV) infection. Tesamorelin + Ipamorelin (6mg/2mg) Blend: Medical Uses & Applications This peptide combination is primarily used for metabolic, anti-aging, and body composition benefits. Here’s a breakdown of its primary medical and off-label uses: 1. Approved Medical Use (FDA-Approved for HIV Lipodystrophy) ✅ Tesamorelin (6mg) FDA-approved to treat HIV-associated lipodystrophy (excess belly fat caused by antiretroviral therapy). Mechanism: Stimulates growth hormone (GH) release, reducing visceral fat. 2. Off-Label & Research-Based Uses A. Fat Loss & Metabolic Health Visceral fat reduction (even in non-HIV patients). Improves insulin sensitivity (potential for metabolic syndrome/type 2 diabetes support). B. Muscle Growth & Recovery Ipamorelin (2mg) is a growth hormone secretagogue (GHS) that: Boosts lean muscle mass. Enhances post-workout recovery. C. Anti-Aging & Longevity Increases collagen production (improves skin elasticity). May support cognitive function (GH plays a role in brain health). D. Injury & Tissue Repair Accelerates healing of tendons/ligaments (used by athletes). 3. Typical Treatment Protocol Dosage: Tesamorelin: 1-2mg/day (often 6mg total per week). Ipamorelin: 200-300mcg/day (2mg total per week). Administration: Subcutaneous injections (stomach or thigh). Cycle Length: 8-12 weeks (with breaks to avoid GH desensitization). 4. Key Benefits vs. Other Peptides Peptide Primary Use Pros Cons Tesamorelin FDA-approved fat loss Targets stubborn belly fat Expensive, requires prescri Final Verdict This blend is best for: ✔ Men/women targeting stubborn fat (especially abdominal). ✔ Athletes seeking muscle recovery & anti-aging benefits. ✔ Those wanting a safer alternative to synthetic GH. 4. Typical Dosage & Protocol Tesamorelin: 1-2mg/day (or 6mg/week). Ipamorelin: 200-300mcg/day (or 2mg/week). Administration: Subcutaneous injection (stomach/thigh). Cycle Length: 8-12 weeks (followed by a break to avoid GH resistance). 3. How It Works Tesamorelin → Stimulates pituitary GH release → Reduces visceral fat. 5. Expected Results & Timeline 📌 4-6 Weeks: Reduced belly fat, improved energy. 📌 8-12 Weeks: Visible muscle definition, better skin elasticity. 📌 Beyond 3 Months: Enhanced recovery, potential cognitive benefits. 5. Expected Results & Timeline 📌 4-6 Weeks: Reduced belly fat, improved energy. 📌 8-12 Weeks: Visible muscle definition, better skin elasticity. 📌 Beyond 3 Months: Enhanced recovery, potential cognitive benefits. 5. Expected Results & Timeline 📌 4-6 Weeks: Reduced belly fat, improved energy. 📌 8-12 Weeks: Visible muscle definition, better skin elasticity. 📌 Beyond 3 Months: Enhanced recovery, potential cognitive benefits. (Best when combined with diet + exercise) . Rare (serious): Increased blood sugar (caution for diabetics). Carpal tunnel syndrome (high doses). Final Verdict ✅ Best for: Men/women struggling with belly fat. Athletes seeking muscle recovery + anti-aging. Those wanting GH benefits without synthetic HGH risks. ❌ Not for: Quick fixes – requires consistent use for 2-3 months Tesamorelin, known for reducing abdominal fat in HIV patients with lipodystrophy, together with Ipamorelin, a growth hormone-releasing peptide, can enhance overall body composition improvements. Furthermore, both substances may work synergistically to boost muscle growth, fat loss, recovery, and anti-aging effects, maximizing the benefits of each peptide when used in tandem. Before taking this medicine You should not use tesamorelin if you are allergic to it, or if you have: cancer; a pituitary gland disorder; a history of pituitary gland tumor or surgery; a history of head injury or radiation treatment; or if you are pregnant. To make sure you can safely take tesamorelin, tell your doctor if you have any of these other conditions: a history of cancer or any tumor (either benign or malignant); heart disease, high blood pressure; kidney disease; diabetes, eye problems caused by diabetes; epilepsy asthma; migraine headaches; adrenal gland disorder; if you have ever had open heart surgery; or if you have any major illness, a recent trauma, or a medical emergency. FDA pregnancy category X. This medication can harm an unborn baby or cause birth defects. Do not use tesamorelin if you are pregnant. Tell your doctor right away if you become pregnant during treatment. Women with HIV or AIDS should not breastfeed a baby. Even if your baby is born without HIV, the virus may be passed to the baby in your breast milk. WE EXPORT IN USA WE EXPORT IN UK WE EXPORT IN AUSTRALIA WE EXPORT IN CANADA WE EXPORT IN SINGAPORE

Semaglutide 3mg USES Brand Name: Rybelsus Formulation: Oral tablet Dosing: Once daily, taken on an empty stomach with water Type 2 Diabetes Management (Primary Use) Initial dose: 3 mg is used as a starting dose to allow the body to adjust to the medication. It is not therapeutic on its own—patients are usually titrated to 7 mg or 14 mg for full glucose-lowering effect. Helps lower blood sugar (HbA1c) in adults with Type 2 diabetes. How It Works. Semaglutide is a GLP-1 receptor agonist, which: Stimulates insulin secretion (when glucose is high) Reduces glucagon secretion Slows gastric emptying Reduces appetite (mildly at this dose) DOSAGE :- Start at 0.25 mg once weekly. After 4 weeks, increase the dose to 0.5 mg once weekly. If after at least 4 weeks additional glycemic control is needed, increase to 1 mg once weekly (2.1).  Administer once weekly at any time of day, with or without meals  If a dose is missed administer within 5 days of missed dose  Inject subcutaneously in the abdomen, thigh, or upper arm Indications & Uses Initial dose for Type 2 diabetes mellitus treatment (used for 30 days before titration to 7 mg or 14 mg) Helps lower blood glucose (HbA1c) Used in combination with diet and exercise Wegovy (semaglutide) for weight loss Wegovy (semaglutide) is used for weight loss and weight maintenance in patients 12 years and older with obesity Used for reducing major cardiovascular event risks (such as heart attack, stroke, or death) in adults with type 2 diabetes with known heart disease Injection is given 1 time a week under the skin of the stomach (belly), the thigh, or the upper arm, using an autoinjector (pen) This injection should be used in addition to a reduced-calorie diet and increased physical activity